文献速递神经肌肉病

小纤维神经病的发病率、患病率、纵向损害与残疾

Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability.
PubMed 文献 · Neurology · 2021-10-27

SFN发病率为1.3/10万人年且研究期间上升,患病率为13.3/10万;患者多不出现重大神经损害或残疾,但合并症多、心肌梗死和死亡风险增高,且随时间常出现大纤维受累和糖尿病。

要点

  • SFN发病率为1.3/10万人年且研究期间上升,患病率为13.3/10万。
  • 患者多不自我认定残疾,但合并症负担和心肌梗死风险显著高于对照。
  • 36%患者平均在SFN起病5.3年后出现大纤维神经病,糖尿病常见。

核心结论

  • 孤立性SFN不常见但发病率在上升,多数患者无重大神经损害或残疾,但合并症多、心血管缺血事件和死亡风险增加。

主要发现

  • SFN发病率为1.3/10万人年且研究期间上升,患病率为13.3/10万,平均随访6.1年,平均起病年龄54岁。
  • 女性占67%,肥胖(BMI平均30.4 vs 28.5 kg/m2)、失眠(86% vs 54%)、阿片类镇痛药处方(72% vs 46%)、高甘油三酯血症(平均180 vs 147 mg/dL)和糖尿病(51% vs 22%,p < 0.001)在SFN组更常见(OR 3.8-9.0,均p < 0.03)。
  • SFN组改良Rankin量表评分中位数1.0(范围0-6) vs 对照0.0(0-6)(p = 0.04),Charlson合并症中位数6(范围3-9) vs 3(范围1-9)(p < 0.001),心肌梗死发生率46% vs 27%(p < 0.0001)。
  • 病因分类包括特发性70%、糖尿病15%、干燥综合征2%、AL淀粉样变1%、转甲状腺素蛋白淀粉样变1%、Fabry病1%、狼疮1%、病毒感染后1%、路易体病1%和多因素5%。
  • 足部溃疡发生在17例中,其中71%有糖尿病;36%患者平均在SFN起病5.3年后出现大纤维神经病;仅AL淀粉样变、遗传性转甲状腺素蛋白淀粉样变、Fabry病、未控制糖尿病和路易体病患者NIS评分和CASS年变化>1分。

临床怎么用

  • 对SFN患者应筛查糖尿病、高甘油三酯血症、肥胖、失眠及心血管缺血事件等合并症,并针对糖尿病、风湿免疫病和罕见遗传病进行靶向检测以指导干预治疗。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: There are limited population-based data on small fiber neuropathy (SFN). We wished to determine SFN incidence, prevalence, comorbid conditions, longitudinal impairments, and disabilities. METHODS: Test-confirmed patients with SFN in Olmsted, Minnesota, and adjacent counties were compared 3:1 to matched controls (January 1, 1998-December 31, 2017). RESULTS: Ninety-four patients with SFN were identified, with an incidence of 1.3/100,000/y that increased over the study period and a prevalence of 13.3 per 100,000. Average follow-up was 6.1 years (0.7-43 years), and mean onset age was 54 years (range 14-83 years). Female sex (67%), obesity (body mass index mean 30.4 vs 28.5 kg/m2), insomnia (86% vs 54%), analgesic-opioid prescriptions (72% vs 46%), hypertriglyceridemia (180 mg/dL mean vs 147 mg/dL), and diabetes (51% vs 22%, p < 0.001) were more common (odds ratio 3.8-9.0, all p < 0.03). Patients with SFN did not self-identify as disabled with a median modified Rankin Scale score of 1.0 (range 0-6) vs 0.0 (0-6) for controls (p = 0.04). Higher Charlson comorbid conditions (median 6, range 3-9) occurred vs controls (median 3, range 1-9, p < 0.001). Myocardial infarctions occurred in 46% vs 27% of controls (p < 0.0001). Classifications included idiopathic (70%); diabetes (15%); Sjögren disease (2%); AL-amyloid (1%); transthyretin-amyloid (1%); Fabry disease (1%); lupus (1%); postviral (1%); Lewy body (1%), and multifactorial (5%). Foot ulcers occurred in 17, with 71% having diabetes. Large fiber neuropathy developed in 36%, on average 5.3 years (range 0.2-14.3 years) from SFN onset. Median onset Composite Autonomic Severity Score (CASS) was 3 (change per year 0.08, range 0-2.0). Median Neuropathy Impairment Scale (NIS) score was 2 at onset (range 0-8, change per year 1.0, range -7.9 to +23.3). NIS score and CASS change >1 point per year occurred in only AL-amyloid, hereditary transthyretin-amyloid, Fabry, uncontrolled diabetes, and Lewy body. Death after symptom onset was higher in patients with SFN (19%) vs controls (12%, p < 0.001), 50% secondary to diabetes complications. DISCUSSION: Isolated SFN is uncommon but increasing in incidence. Most patients do not develop major neurologic impairments and disability but have multiple comorbid conditions, including cardiovascular ischemic events, and increased mortality from SFN onsets. Development of large fiber involvements and diabetes are common over time. Targeted testing facilitates interventional therapies for diabetes but also rheumatologic and rare genetic forms.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Johnson SA, Shouman K, Shelly S, et al. Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability. Neurology. 2021. PMID: 34706972. doi:10.1212/WNL.0000000000012894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。